Skip to main content
Clinical Trials/NCT02139774
NCT02139774
Terminated
Not Applicable

Feasibility of an Evidence-based Walking Program in a Sample of Men Age >65 Undergoing Treatment for Prostate Cancer

UNC Lineberger Comprehensive Cancer Center1 site in 1 country15 target enrollmentOctober 2013
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
UNC Lineberger Comprehensive Cancer Center
Enrollment
15
Locations
1
Primary Endpoint
To measure the feasibility of implementing the WWE intervention among men age >65 with a prostate cancer diagnosis
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

This study is testing a walking program called Walk with Ease by the Arthritis Foundation with men undergoing treatment for prostate cancer. The researchers are interested in how easy or difficult it is for these men to participate in this program and whether or not is is helpful to them during their care.

Detailed Description

Purpose: This pilot study evaluates the feasibility of implementing a moderate-intensity physical activity (PA) program in a sample of men age 65 or older with a prostate cancer diagnosis undergoing various forms of treatment or active surveillance. Participants: Men, 65 and older, with a prostate cancer diagnosis. Procedures (methods): This study will enroll subjects in a 6 week walking program called Walk with Ease (WWE) and see if walking can be sustained for up to three months. In addition, the study will perform a Geriatric Assessment and gather preliminary data on self-reported quality of life outcomes and self-reported physical activity as captured in a daily walking log.

Registry
clinicaltrials.gov
Start Date
October 2013
End Date
June 2014
Last Updated
10 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ≥65 years of age
  • Histologically confirmed Stage I, II or III prostate cancer (endocrine (± radiation) patients may be Stage IV)
  • Undergoing prostate cancer treatment (post-surgery only, radiation only, endocrine therapy (± radiation), or active surveillance)
  • English speaking
  • IRB approved, signed written informed consent
  • Approval from their treating physician to engage in moderate-intensity physical activity
  • Patient-assessed ability to walk and engage in moderate physical activity
  • Willing and able to meet all study requirements

Exclusion Criteria

  • One or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention
  • Major surgery scheduled within the study period
  • Unable to walk or engage in moderate-intensity physical activity
  • Already actively walking (150 minutes per week)

Outcomes

Primary Outcomes

To measure the feasibility of implementing the WWE intervention among men age >65 with a prostate cancer diagnosis

Time Frame: 24 months

Exploring the evaluate the feasibility of implementing the WWE intervention among men age \>65 with a prostate cancer diagnosis. The study will measure those who were able to complete the program and increased their self-reported level of walking. The study will also measure the percent of patients who reach the goal of walking 30 minutes a day for 5 days a week in order to determine feasibility.

Secondary Outcomes

  • Measure the rate of completion for study surveys(24 months)

Study Sites (1)

Loading locations...

Similar Trials